NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1011230057

Registered date:22/01/2024

The effect of remimazolam and propofol on visual evoked potential

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedBrain neoplasm
Date of first enrollment22/01/2024
Target sample size60
Countries of recruitment
Study typeInterventional
Intervention(s)General anesthesia is performed using remimaozolam infusion.

Outcome(s)

Primary OutcomeAmplitude of visual evoked potential at Oz between N1-P1
Secondary OutcomeAmplitude of visual evoked potential at Oz between P1-N2 Latency of visual evoked potential at N1, P1 and N2 Hemodynamic state including blood pressure and heart rate Depth of sedation evaluated by bistral index value

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteriaPatients who undergo neurosurgery using VEP monitoring Patients whose age more than 20 yrs
Exclude criteriaPatients who VEP monitoring can not be performed appropriately

Related Information

Contact

Public contact
Name Tomohiro Chaki
Address 291, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, Japan Hokkaido Japan 0608543
Telephone +81-9070518560
E-mail chakitomohiro0728@yahoo.co.jp
Affiliation Sapporo Medical University School of Medicine Hospital
Scientific contact
Name Tomohiro Chaki
Address 291, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, Japan Hokkaido Japan 0608543
Telephone +81-9070518560
E-mail chakitomohiro0728@yahoo.co.jp
Affiliation Sapporo Medical University School of Medicine Hospital